Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and ...

New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing ...

CytoAgents Inc. (the Company), a clinical-stage biotechnology company, dedicated to developing a safe and effective treatment for Cytokine Release Syndrome (CRS), announced today that it has been ...

Researchers developed a quick and affordable whole-blood assay to detect autoantibodies against type I IFNs, enabling rapid diagnostics for immune disorders. This new method has potential clinical ...

NEW YORK, Sept. 25, 2024 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced platform-wide support for bispecific antibodies. This support includes Remote ...

Responder analyses demonstrated that approximately nine out of 10 patients treated with BIMZELX who achieved PASI90 at Year 1, and over seven out of 10 patients who achieved complete skin clearance ...

The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting ...

Innate-like T cells were found to mature differently in humans than in mice, with age playing a critical role.

Immunoengineering research by Johns Hopkins biomedical engineers was recently featured on the cover of the journal JCI ...

Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors.

The transformative capacity of cells as therapeutics has revolutionised malignancy treatments.1 Cellular engineering advances ...

CAMBRIDGE, Mass., September 25, 2024--2seventy bio, Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with ...